Listen to an audio podcast of the November 28, 2023, FDA Drug Safety Communication, FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan).
Similar Posts
Field Safety Notices: 19 to 23 May 2025
List of Field Safety Notices from 19 to 23 May 2025.
CDERLearn
Training and Education for healthcare professionals, academia, and consumers from FDA’s Center for Drug Evaluation and Research

The Essentials of Blogging: Tips and Strategies for Success
Introduction Welcome to the world of blogging! Whether you’re a beginner looking to start your journey or an experienced blogger aiming to enhance your skills, this post is designed to provide valuable insights and strategies for successful blogging. Blogging is not just about writing; it’s an art that involves engaging your audience, sharing your knowledge,…
OII Vibrant K9. Oak Hills, CA. Sample Analysis issued 03/23/2020
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 03/23/2020
Short Title (70 char) Vibrant K9. Oak Hills, CA. Sample Analysis issued 03/23/2020
FEI Number 3016619230
Firm Name Vibrant K9
Record Type Sample Analysis
State CA
Establishment Type Pet Food Manufactu
Record Date 03/23/2020
Short Title (70 char) Vibrant K9. Oak Hills, CA. Sample Analysis issued 03/23/2020
FEI Number 3016619230
Firm Name Vibrant K9
Record Type Sample Analysis
State CA
Establishment Type Pet Food Manufactu
M11 Template: Clinical Electronic Structured Harmonised Protocol (CeSHarP)
Clinical Electronic Structured Harmonised Protocol
Samsung Bioepis Co. Ltd. – 11/22/2204
Samsung Bioepis Co. Ltd. – 11/22/2204. Country: Republic of (South), Korea. Record Type: 483